An open-label safety study to evaluate the use of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) [lidocaine/tetracaine] in adult patients undergoing a minor or major dermal procedure
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2012
At a glance
- Drugs Lidocaine/tetracaine (Primary)
- Indications Procedural pain
- Focus Adverse reactions
- Sponsors ZARS Pharma
- 12 Jun 2012 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 05 Jun 2012 Actual patient number is 408 according to ClinicalTrials.gov.
- 05 Jun 2012 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.